XML 37 R25.htm IDEA: XBRL DOCUMENT v3.21.2
Summary of significant accounting policies - Narrative (Details)
3 Months Ended 9 Months Ended
Sep. 30, 2021
USD ($)
Sep. 30, 2020
USD ($)
Sep. 30, 2021
USD ($)
segment
Sep. 30, 2020
USD ($)
Dec. 31, 2020
USD ($)
Research and Development Expense [Abstract]          
Reverse stock split ratio     0.1667    
Deferred offering costs $ 300,000   $ 300,000   $ 0
Restricted cash 100,000 $ 100,000 100,000 $ 100,000 $ 100,000
Change in fair value of warrant liability   5,549,000   5,549,000  
Research and development expense $ 0 $ 0 $ 0 $ 0  
Number of operating segments | segment     1